Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -0.73% vs 20.75% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -100.68% vs -43.51% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 992.68% vs -89.57% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 235.04% vs 28.04% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Nath Bio-Genes With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -21.79% vs 50.42% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -0.73% vs 20.75% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -100.63% vs -66.80% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -100.68% vs -43.51% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 25.14% vs -41.41% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 992.68% vs -89.57% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 1.10% vs 24.04% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 235.04% vs 28.04% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






